(19)
(11) EP 3 247 395 A1

(12)

(43) Date of publication:
29.11.2017 Bulletin 2017/48

(21) Application number: 16740510.9

(22) Date of filing: 11.01.2016
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
(86) International application number:
PCT/US2016/012854
(87) International publication number:
WO 2016/118353 (28.07.2016 Gazette 2016/30)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 23.01.2015 US 201562106995 P

(71) Applicant: Immunomedics, Inc.
Morris Plains, NJ 07950 (US)

(72) Inventors:
  • GOLDENBERG, David, M.
    Morris Plains, NJ 07950 (US)
  • WEGENER, William, A.
    Morris Plains, NJ 07950 (US)

(74) Representative: Bohmann, Armin K. 
Bohmann Anwaltssozietät Nymphenburger Straße 1
80335 München
80335 München (DE)

   


(54) COMBINATION THERAPY WITH ANTI-CD74 AND ANTI-CD20 ANTIBODIES IN PATIENTS WITH RELAPSED AND REFRACTORY B-CELL NON-HODGKIN'S LYMPHOMA